DDX41 and myelodysplastic syndrome: Notably, Reactome Pathway analysis highlighted the immune response pathway in DDX41-low CD34+ HSPCs from MDS patients; there was a strong correlation between upregulation of genes involved in innate immune response and high counts of BM blasts (31).